This study, to our knowledge, is the first to evaluate in postmenopausal women the association between IGF-I/IR-related genetic variants and CRC risk using mediation analysis to determine the extent to which CRC–SNP relationship is explained by metabolic biomarkers (i.e., IGF/IR traits). This evidence concerns the gene IGF1 and colorectal carcinoma.